# BUPIVACAINE HCI

NDC: 51662-1581
Generic name: BUPIVACAINE HCI
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INFILTRATION, PERINEURAL
Marketing started: 20220710

FDA application: ANDA207183

## Active ingredients

- BUPIVACAINE HYDROCHLORIDE: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1581"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1581
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e37e1599-db88-2fcd-e053-2995a90a00e5